1. Effect of neoadjuvant liver-directed therapy prior to hepatic resection. (2021) Authors: Mangieri, C.; Strode, M.; Valenzuela, C.; Erali, R.; Shen, P.; Howerton, R.; Clark, C. Journal: HPB Issue: Volume 23(2021)Supplement 2 Page Start: S481 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. High-risk liver patients are not associated with adverse events following pancreaticoduodenectomy. (2021) Authors: Mangieri, C.; Strode, M.; Valenzuela, C.; Erali, R.; Shen, P.; Howerton, R.; Clark, C. Journal: HPB Issue: Volume 23(2021)Supplement 2 Page Start: S517 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Risk factors and outcomes for cholangitis after major hepatic resection. (2021) Authors: Mangieri, C.; Strode, M.; Moaven, O.; Valenzuela, C.; Erali, R.; Howerton, R.; Shen, P.; Clark, C. Journal: HPB Issue: Volume 23(2021)Supplement 2 Page Start: S637 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Use of radiation therapy in neoadjuvany treatment for pancreatic adenocarcinoma decreases risk of postoperative pancreatic fistula: A nsqip analysis. (2020) Authors: Mangieri, C.; Strode, M.; Moaven, O.; Clark, C.; Shen, P. Journal: HPB Issue: Volume 22(2020)Supplement 1 Page Start: S126 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗